Track Koninklijke DSM N.V. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Koninklijke DSM N.V. DSM.AS Open Koninklijke DSM N.V. in new tab

114.05 EUR
Yield
0.82%
Safety Score
82
Loading chart...
Dividend
Dividend Yield0.82%
Annual dividends0.93 EUR
Ex-Div. DateAug. 4, 2022
Payout72.63%

DCF Valuation

Tweak assumptions to recompute fair value for Koninklijke DSM N.V. (DSM.AS)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Koninklijke DSM N.V. Logo Koninklijke DSM N.V. Analysis (DSM.AS)

Netherlands Materials Official Website Stock

Is Koninklijke DSM N.V. a good investment? Koninklijke DSM N.V. (DSM.AS) is currently trading at 114.05 EUR.

For income investors, Koninklijke DSM N.V. pays a dividend yield of 0.82%. With a payout ratio of 73%, the dividend appears sustainable.

Investor FAQ

Does Koninklijke DSM N.V. pay a dividend?

Yes, it pays an annual dividend of 0.93 EUR (0.82% yield).

What asset class is Koninklijke DSM N.V.?

Koninklijke DSM N.V. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Exchange Ticker
AMS (Netherlands) DSM.AS
PNK (United States) KDSKF
Dividend Yield

0.82%

Annual Dividends

0.93 EUR

Next ex. div date

Aug. 4, 2022

Payout Ratio

72.63%

Historical Dividends
Year Total Dividends
2022 2.63 EUR
2021 2.40 EUR
2020 2.43 EUR
2019 2.30 EUR
2018 2.04 EUR
2017 1.20 EUR
2016 1.65 EUR
2015 1.65 EUR
2014 1.70 EUR
2013 1.52 EUR
2012 1.48 EUR
2011 1.40 EUR
2010 1.20 EUR
2009 1.20 EUR
2008 1.27 EUR
2007 2.25 EUR
2006 1.64 EUR
2005 1.75 EUR
2004 1.75 EUR
2003 1.75 EUR
2002 1.86 EUR
2001 1.82 EUR
2000 1.52 EUR

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion